Literature DB >> 11709363

Expression of green fluorescent protein as a marker for effects of antileishmanial compounds in vitro.

S W Kamau1, F Grimm, A B Hehl.   

Abstract

Transgenic Leishmania infantum promastigotes, which constitutively express green fluorescent protein (GFP) in their cytoplasm, were used to monitor the effects of antileishmanial compounds in real time. The GFP-based assay provided a reliable measure of drug-induced inhibitory effects on protein expression, resulting in a dynamic picture of the responses of leishmanial promastigotes to the compounds tested.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11709363      PMCID： PMC90892          DOI： 10.1128/AAC.45.12.3654-3656.2001

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  24 in total

1.  Nuclear envelope fission is linked to cytokinesis in budding yeast.

Authors:  J Lippincott; R Li
Journal:  Exp Cell Res       Date:  2000-11-01       Impact factor: 3.905

2.  Promastigote infectivity in Leishmania infantum.

Authors:  F Grimm; R Brun; L Jenni
Journal:  Parasitol Res       Date:  1991       Impact factor: 2.289

3.  Fluorescent dyes for cell viability: an application on prefixed conditions.

Authors:  C Foglieni; C Meoni; A M Davalli
Journal:  Histochem Cell Biol       Date:  2001-03       Impact factor: 4.304

4.  An axenic amastigote system for drug screening.

Authors:  H L Callahan; A C Portal; R Devereaux; M Grogl
Journal:  Antimicrob Agents Chemother       Date:  1997-04       Impact factor: 5.191

5.  Green fluorescent protein as a marker for gene expression.

Authors:  M Chalfie; Y Tu; G Euskirchen; W W Ward; D C Prasher
Journal:  Science       Date:  1994-02-11       Impact factor: 47.728

6.  Clinical, serologic, and parasitologic follow-up after long-term allopurinol therapy of dogs naturally infected with Leishmania infantum.

Authors:  T Cavaliero; P Arnold; A Mathis; T Glaus; R Hofmann-Lehmann; P Deplazes
Journal:  J Vet Intern Med       Date:  1999 Jul-Aug       Impact factor: 3.333

7.  Use of the green fluorescent protein as a marker in transfected Leishmania.

Authors:  D S Ha; J K Schwarz; S J Turco; S M Beverley
Journal:  Mol Biochem Parasitol       Date:  1996-04       Impact factor: 1.759

8.  Short- and long-term efficacy of hexadecylphosphocholine against established Leishmania infantum infection in BALB/c mice.

Authors:  Y Le Fichoux; D Rousseau; B Ferrua; S Ruette; A Lelièvre; D Grousson; J Kubar
Journal:  Antimicrob Agents Chemother       Date:  1998-03       Impact factor: 5.191

9.  Flow cytometric assessment of allopurinol susceptibility in Leishmania infantum promastigote.

Authors:  S W Kamau; M Hurtado; U U Müller-Doblies; F Grimm; R Nunez
Journal:  Cytometry       Date:  2000-08-01

10.  Green fluorescent protein reporter microplate assay for high-throughput screening of compounds against Mycobacterium tuberculosis.

Authors:  L A Collins; M N Torrero; S G Franzblau
Journal:  Antimicrob Agents Chemother       Date:  1998-02       Impact factor: 5.191
View more
  21 in total

1.  High-throughput growth assay for Toxoplasma gondii using yellow fluorescent protein.

Authors:  Marc-Jan Gubbels; Catherine Li; Boris Striepen
Journal:  Antimicrob Agents Chemother       Date:  2003-01       Impact factor: 5.191

2.  Rab5b localization to early endosomes in the protozoan human pathogen Leishmania donovani.

Authors:  Diane E Marotta; Noel Gerald; Dennis M Dwyer
Journal:  Mol Cell Biochem       Date:  2006-06-03       Impact factor: 3.396

3.  Refractoriness to the treatment of sodium stibogluconate in Indian kala-azar field isolates persist in in vitro and in vivo experimental models.

Authors:  Anuradha Dube; Nasib Singh; Shyam Sundar; Neeloo Singh
Journal:  Parasitol Res       Date:  2005-05-03       Impact factor: 2.289

4.  In vitro screening test using Leishmania promastigotes stably expressing mCherry protein.

Authors:  Paola Vacchina; Miguel A Morales
Journal:  Antimicrob Agents Chemother       Date:  2014-01-06       Impact factor: 5.191

5.  Antileishmanial potential of a marine sponge, Haliclona exigua (Kirkpatrick) against experimental visceral leishmaniasis.

Authors:  Anuradha Dube; Nasib Singh; A Saxena; V Lakshmi
Journal:  Parasitol Res       Date:  2007-02-10       Impact factor: 2.289

6.  An alternative in vitro drug screening test using Leishmania amazonensis transfected with red fluorescent protein.

Authors:  Marcele N Rocha; Célia M Corrêa; Maria N Melo; Stephen M Beverley; Olindo Assis Martins-Filho; Ana Paula Madureira; Rodrigo P Soares
Journal:  Diagn Microbiol Infect Dis       Date:  2013-01-10       Impact factor: 2.803

7.  Real-time in vivo green fluorescent protein imaging of a murine leishmaniasis model as a new tool for Leishmania vaccine and drug discovery.

Authors:  Sanjay R Mehta; Robert Huang; Meng Yang; Xing-Quan Zhang; Bala Kolli; Kwang-Poo Chang; Robert M Hoffman; Yasuyuki Goto; Roberto Badaro; Robert T Schooley
Journal:  Clin Vaccine Immunol       Date:  2008-10-22

8.  Development of a fluorescence-based assay to screen antiviral drugs against Kaposi's sarcoma associated herpesvirus.

Authors:  Tamara K Nun; David J Kroll; Nicholas H Oberlies; Djaja D Soejarto; Ryan J Case; Pius Piskaut; Teatulohi Matainaho; Chelsey Hilscher; Ling Wang; Dirk P Dittmer; Shou-Jian Gao; Blossom Damania
Journal:  Mol Cancer Ther       Date:  2007-08       Impact factor: 6.261

9.  Multifunctional role of human SPLUNC1 in Pseudomonas aeruginosa infection.

Authors:  Sameera Sayeed; Laura Nistico; Claudette St Croix; Y Peter Di
Journal:  Infect Immun       Date:  2012-11-06       Impact factor: 3.441

10.  Simple colorimetric trypanothione reductase-based assay for high-throughput screening of drugs against Leishmania intracellular amastigotes.

Authors:  Erika van den Bogaart; Gerard J Schoone; Paul England; Dorien Faber; Kristina M Orrling; Jean-Claude Dujardin; Shyam Sundar; Henk D F H Schallig; Emily R Adams
Journal:  Antimicrob Agents Chemother       Date:  2013-11-04       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.